JP2021512903A5 - - Google Patents
Info
- Publication number
- JP2021512903A5 JP2021512903A5 JP2020542611A JP2020542611A JP2021512903A5 JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5 JP 2020542611 A JP2020542611 A JP 2020542611A JP 2020542611 A JP2020542611 A JP 2020542611A JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- cell populations
- treg
- tcon
- populations according
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004747A JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628015P | 2018-02-08 | 2018-02-08 | |
| US62/628,015 | 2018-02-08 | ||
| PCT/US2019/017017 WO2019157158A2 (en) | 2018-02-08 | 2019-02-07 | Methods for allogenic hematopoietic stem cell transplantation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Division JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021512903A JP2021512903A (ja) | 2021-05-20 |
| JPWO2019157158A5 JPWO2019157158A5 (https=) | 2022-02-15 |
| JP2021512903A5 true JP2021512903A5 (https=) | 2022-02-15 |
| JP7422667B2 JP7422667B2 (ja) | 2024-01-26 |
Family
ID=67549051
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542611A Active JP7422667B2 (ja) | 2018-02-08 | 2019-02-07 | 同種造血幹細胞移植のための方法 |
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US11952588B2 (https=) |
| EP (2) | EP4529957A3 (https=) |
| JP (2) | JP7422667B2 (https=) |
| CN (1) | CN111971052B (https=) |
| AU (2) | AU2019218792A1 (https=) |
| CA (1) | CA3090175A1 (https=) |
| DK (1) | DK3749334T3 (https=) |
| ES (1) | ES3012854T3 (https=) |
| PL (1) | PL3749334T3 (https=) |
| WO (1) | WO2019157158A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3749334T3 (da) | 2018-02-08 | 2025-02-17 | Univ Leland Stanford Junior | Allogen hæmatopoietisk stamcelletransplantation |
| KR20200130324A (ko) | 2018-02-23 | 2020-11-18 | 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 | Cd83-결합 키메라 항원 수용체 |
| JP7701908B2 (ja) * | 2019-08-16 | 2025-07-02 | エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド | 抗ｃｄ３８キメラ抗原受容体を発現する制御性ｔ細胞 |
| CN117177748A (zh) * | 2020-11-04 | 2023-12-05 | 浩康生物系统公司 | 用于异基因造血干细胞移植的方法 |
| WO2022098926A1 (en) * | 2020-11-04 | 2022-05-12 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| AU2022245339A1 (en) * | 2021-03-25 | 2023-08-31 | Cellenkos, Inc. | Populations of enriched regulatory t cells and methods for producing same |
| EP4426318A4 (en) * | 2021-11-04 | 2025-11-19 | Orca Biosystems Inc | THERAPEUTIC COMPOSITIONS AND TRANSPLANTATION PROCESSES OF ALLOGENEIC HEMATOPOIETIC CELLS |
| AU2023252879A1 (en) * | 2022-04-15 | 2024-11-21 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| EP4709398A2 (en) * | 2023-05-09 | 2026-03-18 | The McLean Hospital Corporation | Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
| US20050163760A1 (en) | 2001-12-06 | 2005-07-28 | Nathalie Cartier-Lacave | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| JP4988172B2 (ja) | 2005-06-24 | 2012-08-01 | 株式会社日立製作所 | 固体酸化物形燃料電池発電システム |
| EP1928479B1 (en) | 2005-08-24 | 2016-06-08 | Yeda Research And Development Co., Ltd. | Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance |
| US8632768B2 (en) | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| US11291686B2 (en) | 2008-05-30 | 2022-04-05 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| WO2010022341A1 (en) | 2008-08-21 | 2010-02-25 | The United State Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching and using regulatory t cells |
| JP5756017B2 (ja) | 2008-11-07 | 2015-07-29 | サニーブルック ヘルス サイエンシズ センター | ヒト前駆ｔ細胞 |
| EP2461828B1 (en) | 2009-07-31 | 2017-06-21 | President and Fellows of Harvard College | Programming of cells for tolerogenic therapies |
| EP2378287A1 (en) | 2010-04-15 | 2011-10-19 | TXCell | New method for isolating Tr1 cells |
| MX370404B (es) | 2011-12-22 | 2019-12-11 | Yeda Res & Dev | Uso de una terapia de combinación para inducir un injerto estable y a largo plazo. |
| WO2013130499A1 (en) | 2012-02-29 | 2013-09-06 | University Of Virginia Patent Foundation | Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment |
| WO2013173076A1 (en) * | 2012-05-04 | 2013-11-21 | University Of Southern California | Methods and compositions for generating and using allogeneic suppressor cells |
| US9376663B2 (en) | 2013-04-02 | 2016-06-28 | New York University | GPR15-mediated homing and uses thereof |
| US11850592B2 (en) | 2017-11-13 | 2023-12-26 | Owl biomedical, Inc. | Particle manipulation system with multisort valve |
| MX389160B (es) * | 2013-10-31 | 2025-03-20 | Hutchinson Fred Cancer Res | Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas. |
| US20170073406A1 (en) | 2014-05-06 | 2017-03-16 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| CA3197849A1 (en) | 2014-12-29 | 2016-07-07 | Novartis Ag | Methods of making chimeric antigen receptor-expressing cells |
| MX2017011194A (es) | 2015-03-03 | 2018-04-10 | Kymab Ltd | Anticuerpos, usos y métodos. |
| JP7062290B2 (ja) | 2015-07-31 | 2022-05-06 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | がんに対する免疫チェックポイント阻害剤との併用療法における造血幹細胞 |
| CN115137752A (zh) | 2015-08-25 | 2022-10-04 | Uab研究基金会 | 用于干细胞移植的方法 |
| KR102768442B1 (ko) | 2015-09-07 | 2025-02-17 | 인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 | CD8+CD45RClow TREGS의 신규한 아집단 및 이들의 용도 |
| CA3003923A1 (en) | 2015-11-05 | 2017-05-11 | Glycostem Therapeutics B.V. | Composition for use in immunotherapy |
| US20190032013A1 (en) | 2016-01-29 | 2019-01-31 | Tract Therapeutics, Inc. | Immune cell selection, expansion, and use |
| WO2017143219A2 (en) | 2016-02-18 | 2017-08-24 | Viera Bioscience, Inc. | Stimulation of therapeutic angiogenesis by t regulatory cells |
| IL261750B2 (en) | 2016-03-14 | 2024-07-01 | Millennium Pharm Inc | Method of preventing graft versus host disease |
| WO2018106610A1 (en) | 2016-12-05 | 2018-06-14 | The Regents Of The University Of California | Immunomagnetic bead-based method to enrich stem cells from whole hematopoietic tissue |
| SG11201908271WA (en) | 2017-03-14 | 2019-10-30 | Juno Therapeutics Inc | Methods for cryogenic storage |
| EP3595683A1 (en) | 2017-03-15 | 2020-01-22 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| US11662343B2 (en) | 2017-04-07 | 2023-05-30 | The Council Of The Queensland Institute Of Medical Research | Cellular populations and uses thereof |
| EP3450981A1 (en) | 2017-08-28 | 2019-03-06 | Trizell GmbH | Btnl8 as a marker for tregs |
| DK3749334T3 (da) | 2018-02-08 | 2025-02-17 | Univ Leland Stanford Junior | Allogen hæmatopoietisk stamcelletransplantation |
| WO2019178106A1 (en) | 2018-03-12 | 2019-09-19 | Medeor Therapeutics, Inc. | Methods for treating non-cancerous disorders using hematopoietic cells |
| US10842821B2 (en) | 2018-04-05 | 2020-11-24 | Medeor Therapeutics, Inc. | Cellular compositions derived from prior organ donors and methods of manufacture and use thereof |
| US10881692B2 (en) | 2018-04-05 | 2021-01-05 | Medeor Therapeutics, Inc. | Compositions for establishing mixed chimerism and methods of manufacture thereof |
| WO2020247341A1 (en) | 2019-06-06 | 2020-12-10 | Medeor Therapeutics, Inc. | Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells |
| WO2022098926A1 (en) | 2020-11-04 | 2022-05-12 | Orca Biosystems, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
-
2019
- 2019-02-07 DK DK19750722.1T patent/DK3749334T3/da active
- 2019-02-07 WO PCT/US2019/017017 patent/WO2019157158A2/en not_active Ceased
- 2019-02-07 US US16/967,375 patent/US11952588B2/en active Active
- 2019-02-07 PL PL19750722.1T patent/PL3749334T3/pl unknown
- 2019-02-07 AU AU2019218792A patent/AU2019218792A1/en not_active Abandoned
- 2019-02-07 JP JP2020542611A patent/JP7422667B2/ja active Active
- 2019-02-07 ES ES19750722T patent/ES3012854T3/es active Active
- 2019-02-07 CN CN201980024106.6A patent/CN111971052B/zh active Active
- 2019-02-07 EP EP24218671.6A patent/EP4529957A3/en active Pending
- 2019-02-07 CA CA3090175A patent/CA3090175A1/en active Pending
- 2019-02-07 EP EP19750722.1A patent/EP3749334B1/en active Active
-
2020
- 2020-09-24 US US17/031,187 patent/US20210002613A1/en not_active Abandoned
- 2020-09-24 US US17/031,213 patent/US11447747B2/en active Active
-
2022
- 2022-08-12 US US17/819,463 patent/US20220380729A1/en active Pending
-
2024
- 2024-01-16 JP JP2024004747A patent/JP7652949B2/ja active Active
- 2024-02-26 US US18/587,729 patent/US20240344027A1/en active Pending
-
2025
- 2025-11-19 AU AU2025271013A patent/AU2025271013A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512903A5 (https=) | ||
| Kuzmina et al. | Multipotent mesenchymal stromal cells for the prophylaxis of acute graft‐versus‐host disease—a phase II study | |
| Chang et al. | Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease | |
| Park et al. | Human umbilical cord blood cell grafts for brain ischemia | |
| Svobodova et al. | The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population | |
| Sensebe et al. | Mesenchymal stem cells for clinical application | |
| JP6266726B2 (ja) | 放射線照射または化学物質による傷害を治療するための方法 | |
| Moloudizargari et al. | The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications | |
| US20120269774A1 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
| Aversa et al. | The evolution of T cell depleted haploidentical transplantation | |
| Gao et al. | The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease | |
| Bader et al. | Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells | |
| CN115137753A (zh) | 来自胎盘的自然杀伤细胞 | |
| JPWO2019157158A5 (https=) | ||
| Couban et al. | The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation | |
| Cohen et al. | Augmentation of the phagocytic activity of murine spleen cell populations induced by Adriamycin | |
| Locatelli et al. | Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation | |
| Ukrainskaya et al. | Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study | |
| US20150374755A1 (en) | Treated Cells and Therapeutic Uses | |
| US20150174173A1 (en) | Stem cell treatment for radiation exposure | |
| US20200306302A1 (en) | Treating and inhibiting leukemia with nk-92 cells | |
| Rejeski et al. | Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity | |
| JP6401445B2 (ja) | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 | |
| Baiamonte et al. | Hematopoietic stem cell mobilization for gene therapy: the combination of G-CSF+ plerixafor in patients with beta-thalassemia major provides high yields of CD34+ cells with primitive signatures | |
| Lázár et al. | Difficulties of Mobilization and Harvesting of Hematopoietic Stem Cells in Heavily Pre-Treated Patients |